Home Network Security HIPAA Health Care IT Sarbanes Oxley Health & Disease RUP - Rational Unified Process

:::::::::: Find the Latest Pharming News and Information ::::::::::



Pharming - Sleepless in Midland
A good play on words is always entertaining, but this one spells conduct that could be unhealthy if not hazardous. It's the use of prescription and OTC drugs for purposes other than what they were intended and in higher than...
Pharming plans to file Rhucin BLA with US FDA by end 2010 ...
Netherlands-based biotechnology company Pharming Group NV (NYSE Euronext: PHARM) says that it intends to submit the Biologic License Application the US Food and Drug Administration to obtain marketing approval for Rhucin (recombinant ...
Drug addiction and factory pharming « Mind Hacks
Drug addiction and factory pharming. Scientific American has a slide show of classic photos from converted prison in 1950s Kentucky which was used as a massive addiction rehabilitation and research centre. The pictures have a slightly ...
Pharming Group N.V.: Pharming plans submission Rhucin BLA to US ...
Investegate, Announcements from Pharming Group NV, Announcement Name.
Phishing and Pharming Protection - Theory and Reality
The UK Centre for the Protection of National Infrastructure (CPNI) have published new guidance on understanding and managing the risks from phishing and pharming.
Blood Pharming Progress
Arteriocyte's Blood Pharming program is currently working to combine multiple state of the art technologies to produce fresh units of universal-donor (Type O, RH factor negative) packed red blood cells. The company's proprietary NANEX ...
Pharming Group Completes Spin-Off Of DNage - News, Search Jobs, Events
Biotech company Pharming Group NV (“Pharming”) (NYSE Euronext: PHARM) today announces that, following the settlement agreement of May 2010 with the former DNage shareholders, which agreement initiated the spin-off of DNage, the spin-off ...
Pharming completes spin-off of DNage
Pharming completes spin-off of DNage, : Biotech company Pharming Group NV announced that, following the settlement agreement of May 2010 with the former DNage shareholders, which agreement initiated the spin-off of DNage, the spin-off ...
Pharming Group Receives Positive Opinion From European Medicines ...
Biotech company Pharming Group NV (“Pharming” or “the Company”) (NYSE Euronext: PHARM) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Ruconest ...
Email-Security: Spam, Spoofing, Phishing, Pharming
The most relevant secondary attacks today include not only spoofing, phishing, and pharming (see GLOSSARY), but also installing a "trojan horse", a computer virus, or crippling your computer with a ransom request to fix it. ...
Pharming And Sanofi Chimie Sign Manufacturing Agreement For The
Pharming And Sanofi Chimie Sign Manufacturing Agreement For The Drug Substance Of Ruconest™ - Pharming Group NV and Sanofi-aventis.
Pharming for Profit: Monsanto Patents Supposedly Safe Method for ...
Pharming for Profit: Monsanto Patents Supposedly Safe Method for Growing Food Crops Containing Insulin, Other Drugs. On May 10, 2005, the United State Patent and Trademark Office (USPTO) issued patent 6891086 for “Plastid Transformation ...
Pharming Group NV : Pharming provides update on outstanding shares
6:02 PM: Pharming provides update on outstanding shares.
Pharming's Supervisory Board nominates CFO
Pharming Group NV announced that the Board of Supervisory Directors (BOSD) has nominated Dr Karl Keegan for appointment as Chief Financial Officer (CFO) and member of the Board of Management of Pharming. ...
UPDATE 1-Pharming to repay debt, raise share capital
Dutch biotech Pharming said on Wednesday it would pay back 10.9 million euros in bonds, its last significant debt, and seek investor approval to raise its authorised share capital to help fund operations.
EuroPharma Today: Latest CHMP positive opinions include Pharming ...
Two small European biotech companies, Pharming and Archimedes, had their lead products, Ruconest and PecFent respectively, recommended for approval by the EU's Committee for Medicinal Products for Human Use at its monthly meeting on ...
Pharming Group Initiates Divestment of DNage, Strong Focus on ...
Upon completion of this first step of the divestment process, Pharming's future earn-out payments due to the former DNage shareholders of up to EUR10 million shall be settled by the issue of 5 million Pharming shares and a 49% share in ...
The Morningstarr* - Blood Pharming program or Genetically ...
In 2008, Darpa, the Pentagon's blue-sky research arm, launched the Blood Pharming program, with the goal of manufacturing mega doses of universal-donor red blood units (O-negative) using a compact, self-contained system. ...
Pharming Group NV : Pharming's Supervisory Board nominates CFO
5:16 PM: Pharming's Supervisory Board nominates CFO.
Pharming to divest DNage, focus on Rhucin - FierceBiotech
Dutch biotech company Pharming Group is planning to divest its wholly owned subsidiary DNage and focus on the commercialization of its lead product, Rhucin, a replacement therapy for patients who... Read more...
Google
 
Web livenewswires.com


Salary Comparison - Search salaries, rates, wages